Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

• The Tuberculosis Trials Consortium

収録刊行物

• The Lancet

  The Lancet 360 (9332), 528-534, 2002-08

  Elsevier BV

キーワード

• General Medicine

詳細情報

• CRID: 1360574096510632576
• NII論文ID: 30005709707
• DOI: 10.1016/s0140-6736(02)09742-8
• ISSN: 01406736
• Web Site: https://api.elsevier.com/content/article/PII:S0140673602097428?httpAccept=text/xml
• Web Site: https://api.elsevier.com/content/article/PII:S0140673602097428?httpAccept=text/plain
• データソース種別:
  • Crossref
  • CiNii Articles